What is the Impact Factor of Neuroimmunomodulation?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Neuroimmunomodulation is 3.70, ranking in quartile Q2 of Web of Science (SCIE).

Is Neuroimmunomodulation indexed in Web of Science or Scopus?

Yes, Neuroimmunomodulation is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.801 (Q2) and an H-index of 78.

Who publishes Neuroimmunomodulation and what is the Article Processing Charge (APC)?

Neuroimmunomodulation is published by S. Karger AG. The estimated Article Processing Charge (APC) is approximately $3,078 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Neuroimmunomodulation?

The official ISO-4 abbreviation of Neuroimmunomodulation is "NEUROIMMUNOMODULAT". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #6,905Gold OA

Neuroimmunomodulation

Abbreviation (ISO):NEUROIMMUNOMODULAT

•

Identifier (ISSN):1021-7401(Print)/1423-0216(Online)

•

Publisher:S. Karger AG

Official Website Submission Portal Compare

Clarivate IF (2026)

3.7↑ +1.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neuroimmunomodulation

WoS Q2

Annual Impact Factor Metric

Current (2026):3.7

Scopus SJR & RankScopus Q2

0.801

#6,905

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

78 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate4.5%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

66articles/year

100% Gold OA•86.21% Original Research

Aims & Scope

The rapidly expanding area of research known as neuroimmunomodulation explores the way in which the nervous system interacts with the immune system via neural, hormonal, and paracrine actions. Encompassing both basic and clinical research, 'Neuroimmunomodulation' reports on all aspects of these interactions. Basic investigations consider all neural and humoral networks from molecular genetics through cell regulation to integrative systems of the body. The journal also aims to clarify the basic mechanisms involved in the pathogenesis of the CNS pathology in AIDS patients and in various neurodegenerative diseases. Although primarily devoted to research articles, timely reviews are published on a regular basis.

Topics Covered (Recognized by AI)

Medicine94.5%Biology93.5%Internal medicine83.1%Genetics75.9%Immunology72.9%Psychology69.3%Chemistry67.6%Endocrinology67.5%Biochemistry65%Neuroscience54.6%Immune system39.2%Pathology34.2%Receptor33.2%Psychiatry29.3%Inflammation29.1%

Primary Research Areas

Medicine Immunology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank83/198

IndexSCIE

JCRSCIE2026

IMMUNOLOGY

Rank85/183

IndexSCIE

JCRSCIE2026

NEUROSCIENCES

Rank126/330

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank125/198

IndexSCIE

JCISCIE2026

IMMUNOLOGY

Rank122/183

IndexSCIE

JCISCIE2026

NEUROSCIENCES

Rank240/330

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	83/198	Q2
IMMUNOLOGY	JCRSCIE	85/183	Q2
NEUROSCIENCES	JCRSCIE	126/330	Q2
ENDOCRINOLOGY & METABOLISM	JCISCIE	125/198	Q3
IMMUNOLOGY	JCISCIE	122/183	Q3
NEUROSCIENCES	JCISCIE	240/330	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.7

Articles / Year22

Total Citations4

2025

IF2.4

Articles / Year27

Total Citations74

2024

IF2.2

Articles / Year24

Total Citations77

2023

IF2.4

Articles / Year36

Total Citations398

2022

IF2.795

Articles / Year42

Total Citations249

Year	Impact Factor	Articles / Year	Total Citations
2026	3.7	22	4
2025	2.4	27	74
2024	2.2	24	77
2023	2.4	36	398
2022	2.795	42	249
2021	2.492	65	881
2020	1.685	31	321
2019	1.351	40	542
2018	2.238	48	1,000
2017	—	44	756
2016	—	41	675
2015	—	30	383

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,905Scopus Q2SCImago Profile

Scopus Coverage:1994-2002, 2004-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyNeuroscience

Scopus Citation Rank (SJR)Q2

0.801

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.36

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,078 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations302

3-Year Documents109

Citable Documents105

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate35.2%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

EndocrinologyQ2

NeurologyQ2

Endocrine and Autonomic SystemsQ3

ImmunologyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 4.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

4区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuroimmunomodulation (abbr: NEUROIMMUNOMODULAT, ISSN: 1021-7401) is a peer-reviewed international scholarly journal in the field of Medicine, published by S. Karger AG in Switzerland since 1994. The periodical holds a Journal Impact Factor (JIF) of 3.70, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.801 (Q2), an H-index of 78.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 66 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,078 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.